| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |